According to the latest data from the Hong Kong Stock Exchange, on February 4, Norges Bank sold 1,834,200 shares of Pharmaron (03759) at a price of HK$20.4681 per share. The total value of the transaction was approximately HK$37.54 million. Following this reduction, the bank's shareholding in the company stands at approximately 20.74 million shares, representing a stake of 5.88%.